Atlas Trials

ALK-positive Advanced NSCLC

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch ALK-positive Advanced NSCLC

RecordFirmDate
A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (NCT03535740)Ariad Pharmaceuticals2019-01-31
Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) (NCT03410108)Takeda2018-01-29
Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients (NCT02511184)Pfizer2015-10-01

Track ALK-positive Advanced NSCLC automatically

Every clearance here is in the API, with alerts when new ones post.